Basics |
Company: |
Dyadic International, Inc. |
IPO Date: |
February 1, 2008 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$51.49M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.13 | 3.48%
|
Avg Daily Range (30 D): |
$0.12 | 6.71%
|
Avg Daily Range (90 D): |
$0.07 | 4.77%
|
Institutional Daily Volume |
Avg Daily Volume: |
.25M |
Avg Daily Volume (30 D): |
.1M |
Avg Daily Volume (90 D): |
.06M |
Trade Size |
Avg Trade Size (Sh.): |
226 |
Avg Trade Size (Sh.) (30 D): |
330 |
Avg Trade Size (Sh.) (90 D): |
312 |
Institutional Trades |
Total Inst.Trades: |
19 |
Avg Inst. Trade: |
$2.18M |
Avg Inst. Trade (30 D): |
$M |
Avg Inst. Trade (90 D): |
$M |
Avg Inst. Trade Volume: |
.33M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$4.07M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
600.59K |
|
|
|
|
News |
Oct 9, 2024 @ 12:00 PM
Dyadic Expands Global Presence with Participation ...
Source: N/A
|
Jun 28, 2024 @ 12:30 PM
Dyadic International, Inc. and Proliant Health and...
Source: Dyadic International, Inc.
|
May 8, 2024 @ 12:30 PM
Dyadic to Attend Industry and Investor Events in M...
Source: Dyadic International, Inc.
|
Apr 30, 2024 @ 8:30 PM
Dyadic to Report First Quarter 2024 Financial Resu...
Source: Dyadic International, Inc.
|
Mar 28, 2024 @ 8:00 PM
Dyadic Reports 2023 Full Year Results and Recent C...
Source: Dyadic International, Inc.
|
Financials |
|
TTM |
Q2 2024 |
Q1 2024 |
Basic EPS
|
$-.01
|
$-.07
|
$-.07
|
Diluted EPS
|
|
|
|
Revenue
|
$ 1.96M
|
$ .39M
|
$ .33M
|
Gross Profit
|
$ 1.56M
|
$ .08M
|
$ .19M
|
Net Income / Loss
|
$ -.2M
|
$ -2.05M
|
$ -2.01M
|
Operating Income / Loss
|
$ -.2M
|
$ -2.04M
|
$ -2.13M
|
Cost of Revenue
|
$ .4M
|
$ .3M
|
$ .14M
|
Net Cash Flow
|
$ -.21M
|
$ -4.44M
|
$ 4.06M
|
PE Ratio
|
|
|
|
|